These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 10528211

  • 1. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A.
    J Immunol; 1999 Nov 01; 163(9):5056-63. PubMed ID: 10528211
    [Abstract] [Full Text] [Related]

  • 2. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA, Frank MM, Tenner AJ.
    Eur J Immunol; 1988 Dec 01; 18(12):2001-7. PubMed ID: 2975599
    [Abstract] [Full Text] [Related]

  • 3. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB, Clemenza L, Krych M, Atkinson JP.
    J Immunol; 1996 Aug 01; 157(3):1242-7. PubMed ID: 8757632
    [Abstract] [Full Text] [Related]

  • 4. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W, Burdick G, Carl V, Lachmann PJ.
    J Immunol; 1989 Jun 15; 142(12):4366-71. PubMed ID: 2524529
    [Abstract] [Full Text] [Related]

  • 5. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL, Takahashi H, Rudick RA, Knutson DW.
    J Immunol; 1986 Mar 01; 136(5):1765-71. PubMed ID: 2936811
    [Abstract] [Full Text] [Related]

  • 6. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA, Ng YC, Paccaud JP, Walport MJ.
    Clin Exp Immunol; 1989 Mar 01; 75(3):329-35. PubMed ID: 2522842
    [Abstract] [Full Text] [Related]

  • 7. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC, McDuffie FC, Tappeiner G, Jordon RE.
    Immunology; 1978 Apr 01; 34(4):751-61. PubMed ID: 102587
    [Abstract] [Full Text] [Related]

  • 8. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA, Ng YC, Estreicher J, Walport MJ.
    J Immunol; 1988 Feb 01; 140(3):899-904. PubMed ID: 2963069
    [Abstract] [Full Text] [Related]

  • 9. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A, Walter W, Teshima H, Boumsell L, Good RA, Day NK.
    J Immunol; 1976 Oct 01; 117(4):1117-26. PubMed ID: 977945
    [Abstract] [Full Text] [Related]

  • 10. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E, Sorvillo J, Gigli I.
    J Immunol; 1982 May 01; 128(5):2036-9. PubMed ID: 6801128
    [Abstract] [Full Text] [Related]

  • 11. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
    Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A.
    Immunity; 1997 Sep 01; 7(3):345-55. PubMed ID: 9324355
    [Abstract] [Full Text] [Related]

  • 12. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN, Parish CR, Easterbrook Smith SB, Altin JG.
    Biochemistry; 1997 Jun 03; 36(22):6653-62. PubMed ID: 9184145
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD, Mold C.
    Clin Exp Immunol; 1997 Nov 03; 110(2):310-6. PubMed ID: 9367418
    [Abstract] [Full Text] [Related]

  • 14. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI, Hale G, Waldmann H.
    Eur J Immunol; 1990 Feb 03; 20(2):277-81. PubMed ID: 2311645
    [Abstract] [Full Text] [Related]

  • 15. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 16. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec 01; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 17. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E, Schumaker VN, Phillips ML, Curtiss LK.
    J Immunol; 1986 Jul 01; 137(1):255-62. PubMed ID: 3486914
    [Abstract] [Full Text] [Related]

  • 18. Identification of complement receptor type 1-related proteins on primate erythrocytes.
    Nickells MW, Subramanian VB, Clemenza L, Atkinson JP.
    J Immunol; 1995 Mar 15; 154(6):2829-37. PubMed ID: 7876553
    [Abstract] [Full Text] [Related]

  • 19. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR, Fearon DT.
    J Immunol; 1994 Mar 15; 152(6):2899-903. PubMed ID: 8144890
    [Abstract] [Full Text] [Related]

  • 20. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR, Miltenburg AM, Hiemstra PS, Klar-Mohamad N, Van Es LA, Van Hinsbergh VW.
    Eur J Immunol; 1988 May 15; 18(5):783-7. PubMed ID: 3259929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.